Anthony Tabasso, CEO of KVK Tech, talks with Chief Executive about the challenges in manufacturing a controlled substance, a highly-regulated industry, and manufacturing generic medications with lower price pressure.
As 3D printing technologies and new materials open the doors for increasingly complex products, we’re on the verge of manufacturing life-saving products that could alter the course of history.
The U.S. Department of Commerce has awarded $70 million in funding to the new National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). It is the eleventh institute in the Manufacturing USA network and the first with a focus area proposed by industry and funded by the Department of Commerce.
How Aaron Bensimon’s experiments with the elasticity of DNA molecules evolved into a thriving biotech firm.